QSI trades 110.7% below Wall Street's consensus target of $2.95.
Last 12 months price action with 12-month analyst target path
The base valuation assumes QSI achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 24, 2026, Quantum-Si incorporated (QSI) has a Wall Street consensus price target of $2.95, based on estimates from 2 covering analysts. With the stock currently trading at $1.40, this represents a potential upside of +110.7%. The company has a market capitalization of $277M.
Analyst price targets range from a low of $1.90 to a high of $4.00, representing a 71% spread in expectations. The median target of $2.95 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, QSI trades at a trailing P/E of -2.7x. Analysts expect EPS to grow +4.8% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 PACBPacific Biosciences of California, Inc. | $655M | $2.11 | $1.93 | -8.5% | Buy | — | 18 |
 CDNACareDx, Inc | $3.6B | $69.21 | $62.25 | -10.1% | Buy | 57.8x | 14 |
 ACMRACM Research, Inc. | $3.2B | $50.55 | $113.20 | +123.9% | Buy | 22.8x | 10 |
 ILMNIllumina, Inc. | $40.8B | $269.42 | $252.73 | -6.2% | Buy | 50.3x | 50 |
 FLGTFulgent Genetics, Inc. | $571M | $20.10 | $19.00 | -5.5% | Buy | — | 9 |
 SEERSeer, Inc. | $108M | $1.97 | $4.00 | +103.0% | Hold | — | 4 |
 TMOThermo Fisher Scientific Inc. | $250.4B | $673.82 | $688.14 | +2.1% | Buy | 26.7x | 43 |
 DHRDanaher Corporation | $162.0B | $230.50 | $238.77 | +3.6% | Buy | 26.9x | 43 |
 AAgilent Technologies, Inc. | $48.9B | $173.07 | $173.08 | +0.0% | Buy | 27.9x | 41 |
 BIOBio-Rad Laboratories, Inc. | $10.0B | $369.95 | $350.00 | -5.4% | Buy | 37.9x | 14 |
Quick answers to the most common questions about buying QSI stock.
The consensus Wall Street price target for QSI is $2.95, representing 110.7% upside from the current price of $1.4. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
QSI has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $2.95 implies 110.7% upside from current levels.
QSI's current price is $1.4 with a consensus target of $2.95 (110.7% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $4 for QSI, while the most conservative target is $1.9. The consensus of $2.95 represents the median expectation. These targets typically reflect 12-month expectations.
QSI is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month QSI stock forecast based on 2 Wall Street analysts shows a consensus price target of $2.95, with estimates ranging from $1.9 (bear case) to $4 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on QSI, with a "Buy" consensus rating and $2.95 price target (110.7% upside). 1 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
QSI analyst price targets range from $1.9 to $4, a 71% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $2.95 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.